Previous Article | Next Article 
Journal of Virology, December 2000, p. 11067-11072, Vol. 74, No. 23
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Estimating Relative Fitness in Viral
Competition Experiments
Athanasius F. M.
Marée,1
Wilco
Keulen,2
Charles A. B.
Boucher,2 and
Rob J.
De Boer1,*
Theoretical Biology, Utrecht
University,1 and Department of Virology,
University Medical Center Utrecht,2 Utrecht, The
Netherlands
Received 27 March 2000/Accepted 1 September 2000
 |
ABSTRACT |
The relative fitness of viral variants has previously been defined
as the slope of the logarithmic ratio of the genotype or phenotype
frequencies in time plots of pairwise competition experiments. Developing mathematical models for such experiments by employing the
conventional coefficient of selection s, we demonstrate
that this logarithmic ratio gives the fitness difference, rather than the relative fitness. This fitness difference remains proportional to
the actual replication rate realized in the particular experimental setup and hence cannot be extrapolated to other situations. Conversely, the conventional relative fitness (1 + s) should be
more generic. We develop an approach to compute the generic relative
fitness in conventional competition experiments. This involves an
estimation of the total viral replication during the experiment and
requires an estimate of the average lifetime of productively infected
cells. The novel approach is illustrated by estimating the relative
fitness, i.e., the relative replication rate, of a set of
zidovudine-resistant human immunodeficiency virus type 1 variants. A
tool for calculating the relative fitness from observed changes in
viral load and genotype (or phenotype) frequencies is publically
available on the website at
http://www-binf.bio.uu.nl/~rdb/fitness.html.
 |
INTRODUCTION |
Differences in the in vitro
replication rate (or fitness) between viral variants can be estimated
experimentally by pairwise competition experiments in tissue culture.
The outcome of such an experiment is typically depicted in a
logarithmic time plot of the ratio of the genotype or phenotype
frequencies (7). On a logarithmic scale the ratio tends to
change linearly in time, and the rate of change (i.e., the slope of the
line) has previously been defined as the relative fitness
(7). According to population genetics theory, the relative
fitness (1 + s) of a variant represents its relative
contribution to the next generation. The parameter s is
defined as the coefficient of selection. The intertwined concepts of
relative fitness (1 + s) and selection coefficient s are traditionally employed in systems with discrete
generations. They are equally valid for populations growing
continuously, however, when time is scaled with respect to the
generation time (11).
Developing conventional population genetics models for pairwise
competition experiments, we show that the above-mentioned slope in a
logarithmic time plot provides the absolute fitness difference between
the two variants rather than the generic relative fitness (1 + s) of one with respect to the other. As the fitness difference remains proportional to the replication rate realized in the
particular experimental setup, viral strains having similar selection
coefficients s may have large fitness differences. On the
other hand, variants differing markedly in the selection
coefficients will yield almost horizontal lines in logarithmic time
plots when the realized replication rate in the experiment
is sufficiently low. This has indeed caused confusion in the literature
(see Discussion).
Previous work on the fitness of human immunodeficiency virus type 1 (HIV-1) variants has indeed adopted the concept of a selection coefficient s from population genetics (2, 4). It
is unfortunate, therefore, that the slope of the logarithmic time plot
of the ratio of two variants in competition experiments has also been called a relative fitness. We here demonstrate that this slope gives
the (absolute) fitness difference, and we develop a novel approach for
estimating the generic relative fitness (1 + s) by competition experiments.
 |
MATERIALS AND METHODS |
To estimate selection coefficients, one conventionally writes
simple exponential growth models for the various viral variants. Since
viral growth need not be exponential, we first derive a somewhat more
realistic model that, however, has to remain sufficiently generic for
estimating selection coefficients of different viruses under different
circumstances. This requires the assumption that the dynamics of free
virus particles are much faster than those of productively infected cells.
A general model for the viral life cycle allows for at least two
stages: free virions and infected cells. Infected cells appear when
virions infect target cells, and virions appear from infected cells.
Let 0
F(t)
1 be a function
representing target cell availability (and/or other factors limiting
viral replication). Considering infectious viral particles V
and productively infected cells I only, we write the
mathematical model
|
(1a and 1b)
|
The parameter
is an infection rate, 1/
is the average
life span of productively infected cells, p is the virion
production rate, and c is the viral clearance rate.
To approach a general population genetics model, this two-compartment
model has to be written as a one-compartment model. Since virion
dynamics are generally faster than the dynamics of productively
infected cells, one typically writes the quasi-steady-state (QSS)
equation V = (p/c)I. Thus, the
free virion concentration is assumed to remain proportional to the
density of productively infected cells. Substitution into equation 1a
yields
|
(2)
|
where
r =
p
/c appears as a
generalized replication rate combining infection

, production
p, and clearance
c. In this QSS
model, viral
variants differing in the clearance rate
c, in the
infection
rate

, and/or in the production rate
p will differ
in
this generalized replication rate
r =
p
/c
only. Importantly,
the parameter

should remain unaffected by such
differences.
In most cases viral variants have different replication rates
(r) rather than different average life times (1/
). We
therefore write models where the selection acts upon the replication
rate. For cases where one knows that selection acts upon the death rate
, one can easily rewrite our model and obtain similar results. When
it is not known whether variants differ in replication or in death
rates, one should set
= 0 and interpret the parameter r as a net replication rate (see Discussion). By setting
= 0, one can see that equation 2 is a generalization of the
conventional exponential growth models.
Copying equation 2, and assuming that selection acts upon replication,
a population genetics model of a competition experiment with a
wild-type virus W and a mutant M is written as
|
(3a and 3b)
|
where
s is the conventional selection coefficient.
This parameter
s is fixed and independent of the
time-dependent conditions
F(
t), and it will
generally be negative. In competition experiments,
one is interested in
the (nondimensional) relative fitness (1
+
s). A
conventional summary of competition experiments is a
logarithmic
time plot of the genotype (or phenotype) ratio
M/W (
7). By
writing exponential
growth, one previously assumed nonlimiting
conditions; i.e., one
assumed
F(
t) = 1 in equations 3, to be able
to write the solutions
W(
t) =
W(0)
e(r
)t and
M(
t) =
M(0)
e[r(1 + s)
]t. From
these solutions one can easily see that the logarithmic
ratio obeys
|
(4)
|
Thus, in a time plot the logarithmic ratio is expected to change
linearly with slope
rs and is expected to be independent
of

. Finally, note that
W need not represent the wild-type
virus
but may equally well represent the "best mutant" when the
competition
experiment involves two
mutants.
 |
RESULTS |
The mathematical model is employed to simulate conventional
competition experiments. Figure 1 depicts
two typical experiments for the typical situation of exponential
growth. The top panels depict the virus density (in arbitrary units),
and the bottom panels depict the logarithmic time plot of the
genotype ratio. Below we will address other in silico (computer)
experimental conditions.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 1.
Simulations of competition experiments under unlimiting
conditions, i.e., F = 1. (A) An in silico experiment of
10 days with r = 1/day and s = 0.1.
(B) A 2-day experiment with a rapidly replicating virus, i.e.,
r = 10/day and s = 0.01. Although the
relative fitness of the mutant is 90% in panel A and 99% in panel B,
the slope of the logarithmic ratio plot rs = 0.1/day is
identical; i.e., the fitness difference is the same (note the
difference in the scales of the horizontal axes). In both panels
= 0.5/day and W(0) = M(0) = 1. The solid lines in the top panels show the total virus concentration
(W + M); the dashed lines show the wild-type virus
W, and the dash and dotted lines show the mutant
M.
|
|
The mathematical model demonstrates that the conventional
approach of estimating the slope in logarithmic time plots of genotype ratios provides an estimate for rs, i.e., the product
of the actual replication rate r and the selection
coefficient s. This is the absolute fitness difference
between the two variants in this particular experiment [i.e., the
mutant replicates at a rate of (r + rs)/day]. Estimating the selection coefficient, and hence
the relative fitness, therefore requires an estimate of the wild-type
replication rate r. Steep slopes of the logarithmic ratios
do not necessarily imply large selection coefficients; a steep slope
may also reflect a high replication rate r. For our in
silico experiments, Fig. 1 illustrates that viruses having a relative
fitness of 90% (Fig. 1A) or of 99% (Fig. 1B) show the same slope on
the logarithmic ratio plot when the replication rates differ 10-fold.
In general this means that fitness differences cannot easily be
extrapolated to other circumstances involving different replication
rates (such as the in vivo situation), because they depend on the
actual replication rate realized under the in vitro tissue culture conditions.
Estimating the replication rate.
Thus, for estimating the
relative fitness of a variant, the replication rate r has to
be determined. The simplest situation is the nonlimiting
condition F(t) = 1, with exponential
growth of both strains. Plotting the natural logarithm of the wild-type virus concentration over time (see the dashed line in Fig. 1A, where we
plot the log10 values), one obtains a straight line with a
slope of (r
)/day, which is the net replication
rate of the wild-type virus. For estimating the selection coefficient
s, however, one needs to know the replication rate
r, whereas the slope gives the net replication rate
(r
). For the in vivo situation
has been
estimated for several viruses (6, 12, 15, 16, 19). There are
limited data on the average lifetime of productively infected cells
(1/
) for the in vitro situation, however. A paper by Gandhi et al.
(3) shows for HIV-1 that in vitro >50% of CD4+
T cells are depleted in 2 to 3 days, suggesting that for HIV-1
may
be similar in vivo and in vitro. Without such in vitro estimates of the lifetime 1/
, estimates of the relative replication rates (1 + s) of viral variants from in vitro competition
experiments remain unreliable. Below we discuss how one typically
ignores this problem and what error this implies (see Discussion).
Limiting conditions.
In typical in vitro competition
experiments the tissue culture conditions do become limiting after some
time. In order to maintain favorable conditions, medium and/or target
cells can be added during the experiment. Both can be accounted for in
the model by allowing the function F(t) to become
smaller than 1 and to change over time (Fig.
2). Two simple theoretical examples are
F(t) = [1
(M + W)/K], which yields logistic growth, and F(t) = exp[
t] representing
deactivation or death of target cells and/or depletion of factors in
the medium. Substituting such a declining F(t)
into the model results in a decline of the viral replication rate
rF(t) over time. As a consequence, the fitness difference, as measured by the slope of the logarithmic ratio, also
declines over time (Fig. 2).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
Competition experiments under limiting conditions, i.e.,
F(t) 1. Both panels depict a 10-day
experiment with r = 2/day, s = 0.1, = 0.5/day, and W(0) = M(0) = 1. In panel A, F(t) = [1 (W + M)/K] with K = 103, and in panel B, F(t) = exp[ t] with = 0.3. Table 1 shows that the
correct selection coefficients can be calculated from the beginning and
end points only. The solid lines in the top panels show the total virus
concentration (W + M); the dashed lines show the wild
type virus W, and the dash and dotted lines show the mutant
M.
|
|
Estimation of the fitness difference under limiting conditions requires
an estimate of the total replication during the experiment.
Provided
that there are data on the viral expansion during the
experiment, there
is a simple solution to this problem. In the
Appendix we derive that
the selection coefficient can be directly
estimated from the initial
and final values of the concentration
of the wild-type virus
W and the genotype ratio
H =
M/W.
For an
experiment of
T days we derive that
|
(5)
|
where
W(
T)/
W(0) is the fold
expansion of the wild-type virus during the experiment and
H(
T)/
H(0) is the fold change in the
M/W ratio over the
T days of the
experiment.
In Table
1 we show that one can
accurately estimate the selection coefficients
s from all
four in silico experiments in Fig.
1 and
2 by this formula (and by
knowing that

= 0.5/day in our
computer experiments). In all
cases we recover the correct coefficient
of selection by considering
only the data at the start and at
the end of the experiment. The
nonlinear time course of the viral
replication during the experiment
remains irrelevant for estimating
the relative fitness.
Experimental data.
To illustrate our approach for the in vitro
situation, Fig. 3 and Table
2 provide examples of data from tissue
culture competition experiments that were set up to estimate
differences in the replication rates of various zidovudine
(AZT)-resistant HIV-1 mutants. Halfway through each experiment of 8 days, the cultures were split in half; i.e., half of the medium and
cells was replenished with fresh medium and cells (Fig. 3). Table 2
shows that the relative fitness can be estimated by considering the
percentage of the mutant virus and the total virus density (as measured
by use of the HIV-1 capsid p24 antigen [CA-p24]) at the start and end
of each experiment. We show in the Appendix that the twofold dilution during the experiment can be corrected for by the ln 2 factor in
equation 14. The relative fitness of the variants varies around 90%.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 3.
Two sequential competition experiments between wild-type
HIV-1 and the AZT-resistant variant M41L/T215Y. Competition experiments
were initiated by infection of phytohemagglutinin-stimulated peripheral
blood mononuclear cells with a virus mixture containing the wild-type
HXB2 virus and the AZT-resistant variant. At day 3, the cells were
washed, and a cell-free sample was taken from the culture for CA-p24
analysis. At day 7, half of the culture was removed, and fresh medium
supplemented with phytohemagglutinin-stimulated peripheral blood
mononuclear cells was added. At day 11, virus supernatant was harvested
and used for CA-p24 analysis, and the ratio of the wild-type to the
mutant genotype frequency was established [H(11)]. The
genotype ratio at day 3 was assumed to be identical to that at day 11 of the previous passage (W. Keulen et al., submitted for publication).
In Table 2 we compute the selection coefficients s = 0.0862 and s = 0.0979 for the two experiments.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Estimation of the coefficient of selection from several
competition experiments between virus with a wild-type reverse
transcriptase gene and several AZT-resistant mutants with point
mutations in the reverse transcriptase genea
|
|
In these experiments the viral density was measured by use of the
CA-p24 antigen. It is important to realize that equation
5 requires
only the fold expansion of the virus during the experiment.
Equation
5
should therefore allow one to measure the viral density
by any type of
assay. Being based upon this nondimensional ratio
only, most scaling
properties of the experimental readout should
cancel. We do, however,
require that the assay be used within
its linear range and that the
readout remain proportional to the
number of productively infected
cells. Note that, due to the possible
accumulation of the CA-p24
antigen, the latter requirement need
not be true for CA-p24. In that
case the selection coefficients
in Table
2 represent lower
bounds.
The in vivo steady state.
Several viruses establish a chronic
infection in their host with an approximately steady-state viral load.
For estimating the relative fitness, such a QSS is a much simpler
situation than the situations involving expanding virus populations
considered above, because one may employ the steady-state equation to
estimate the replication rate (4). For a QSS concentration
of the wild-type virus, equation 3a, with
dW/dt
0, gives
rF(t)
. Thus, the slope of the
logarithmic ratio becomes
s (4). Hence, if
is known, one can divide this slope by
to calculate s.
The population geneticist's way to do this is to scale time with the
estimated generation time 1/
(4).
Multiple mutants.
Competition experiments need not be pairwise
and may instead involve several genotypes at once. Additionally, the in
vivo evolution may involve several genotypes at measurable quantities (4). The multiple strains compete by means of the growth
function that is computed from the expansion of the wild-type virus.
Equation 5 therefore allows one to compute each of the selection
coefficients by considering the expansion of the wild-type virus
W(T)/W(0) (or that of the best
variant) with the respective changes of the genotype ratios
H(T)/H(0) of all variants present in
the experiment.
 |
DISCUSSION |
The concept of a relative fitness as defined by the slope
rs of logarithmic plots of the genotype ratio (7)
has been confused with the relative fitness in population genetics
(1 + s) in several previous publications (see, e.g.,
references 5, 9, 10, and 18).
Since the viral replication rate can become very high under conditions
favoring exponential growth, one may measure a large fitness difference
rs even when the coefficient of selection s is
relatively small. Previous authors have indeed been surprised by the
large fitness differences that were found in the slopes of logarithmic
plots of the genotype ratio (14). Under QSS conditions, such
as a chronic in vivo infection, the replication rate approaches the
death rate. This allows the relative fitness to be obtained by scaling
time to the viral generation time (4). Since this method has
also been applied to non-steady-state conditions (5), there
is even more confusion in the literature. Notwithstanding the confusion
on the underlying mathematical model, it has been recognized that the
outgrowth of viral variants depends on the realized replication rate
(20). Confirming our results, it was demonstrated that the
rate at which a wild-type duck hepatitis B virus replaces an initial
mutant depends on the rate of production of new hepatocytes
(20).
We have shown that realistic estimates of the relative fitness requires
an estimate for the average lifetime of infected cells (1/
).
Although
is known for several viruses in the in vivo situation, it
is not known for typical in vitro conditions. This problem has been
overlooked before because one typically writes models in terms of a net
replication rate incorporating the death rate
[e.g.,
dM/dt = r(1 + s)M]. By developing our model from a model with
infection and production parameters, however, we derived that the
selection coefficient should be independent of the death rate
.
Hence, one requires an estimate of
to estimate selection
coefficients. In our model, we could also interpret the replication
rate r as a net replication rate by setting
= 0 in
equation 3. The Appendix shows that this approximation becomes valid
when r is 
(see, e.g., Fig. 1b). This illustrates an
advantage of performing competition experiments with favorable
unlimiting conditions: high replication rates decrease the effect of
.
If multiple mutants are compared in pairwise competition experiments
with a wild-type virus and there is no information on the replication
rate r, one does obtain a correct ranking of the fitness
differences rs1, rs2,
..., rsn from the respective
logarithmic slopes (provided that the experimental conditions are the
same). This provides information on the fold differences
si/sj in the selection coefficients
between the variants. To estimate how the mutants compare to the wild
type and what the ratios (1 + si)/(1 + sj) in the relative fitnesses are, one still
requires equation 5 however.
The main idea of a relative fitness is that it should allow for
extrapolation to other situations. For instance, knowing the in vivo
replication rate of the wild-type virus (8, 13, 17), one
should be able to multiply this by the relative fitness value (1 + s) to obtain the in vivo replication rate of a variant. A word of caution remains appropriate however. The selection coefficient measured in vitro may depend on the precise in vitro conditions, such
as the nucleotide availability (1) and the initial viral density (18). Thus, although we have provided an algorithm
for estimating the true conventional relative fitness, it remains questionable whether in vitro estimates can be extrapolated to the in
vivo situation.
In summary, we have shown that estimating a generic relative
fitness (1 + s) requires, besides the time course
of the genotype frequencies (7), additional
estimates for the fold expansion of the wild-type virus and the death
rate
of productively infected cells during the competition
experiment. Based upon this information, a simple formula allows one to
estimate the coefficient of selection s. This formula is
available on the website at
http://www-binf.bio.uu.nl/~rdb/fitness.html. A final
advantage of this model is that it explicitly allows replication
rates to change during the experiment when conditions become
limiting and/or by experimental manipulation.
 |
APPENDIX |
In equation 3 we have allowed for changes in the actual
replication rate by writing the replication rate
rF(t). Here we allow the replication
r(t) to be an arbitrary function of the time
t during a competition experiment. The experiment
starts at time t = 0 and ends at time t = T.
First, define the ratio of mutant to wild-type virus as
H = M/W, and define h = ln
H as the logarithmic ratio. From equation 3 one obtains by
the normal rules of differentiation dH/dt = sr(t)H and, hence
|
(6)
|
Thus, the logarithmic ratio
h(
T) at the end
of the experiment is
|
(7)
|
For the wild type virus we follow a similar procedure by first
defining
w = ln
W, and then
d
W/d
t =
r(
t)
W
W yields
|
(8)
|
For the end of the experiment we obtain
|
(9)
|
which, when rewritten as
|
(10)
|
can be substituted in equation 7 to obtain
|
(11)
|
Since
h and
w are logarithms, this can be
rewritten into equation 5 in the
text.
In several experimental setups one refreshes the medium at some point
during the experiment. Consider, for example, a case where one removes
half of the infected cells and medium at time t = Th to add fresh medium and target cells. By this
procedure, equation 9 changes into
|
(12a)
|
and
|
(12b)
|
Since
|
(13)
|
we obtain
|
(14)
|
Thus, halving the number of cells at any time during the
experiment can be corrected for by adding the factor ln 2 to the
denominator.
 |
ACKNOWLEDGMENTS |
We thank André Noest, José Borghans, and James Cohen
Stuart for discussion and comments.
This work is partially supported by a grant from the Dutch AIDS
Foundation (PccO grant 1317). A. F. M. Marée is
supported by the Priority Program Nonlinear Systems of the Netherlands
Organization for Scientific Research.
 |
FOOTNOTES |
*
Corresponding author. Mailing address:
Theoretical Biology, Utrecht University, Padualaan 8, 3584 CH
Utrecht, The Netherlands. Phone: 31 30 253 7560. Fax: 31 30 251 3655. E-mail: R.J.DeBoer{at}bio.uu.nl.
 |
REFERENCES |
| 1.
|
Back, N. K.,
M. Nijhuis,
W. Keulen,
C. A. Boucher,
B. O. Oude Essink,
A. B. Van Kuilenburg,
A. H. Van Gennip, and B. Berkhout.
1996.
Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
EMBO J.
15:4040-4049[Medline].
|
| 2.
|
Coffin, J. M.
1995.
HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.
Science
267:483-489.
|
| 3.
|
Gandhi, R. T.,
B. K. Chen,
S. E. Straus,
J. K. Dale,
M. J. Lenardo, and D. Baltimore.
1998.
HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism.
J. Exp. Med.
187:1113-1122[Abstract/Free Full Text].
|
| 4.
|
Goudsmit, J.,
A. De Ronde,
E. De Rooij, and R. J. De Boer.
1997.
Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215.
J. Virol.
71:4479-4484[Abstract].
|
| 5.
|
Harrigan, P. R.,
S. Bloor, and B. A. Larder.
1998.
Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro.
J. Virol.
72:3773-3778[Abstract/Free Full Text].
|
| 6.
|
Ho, D. D.,
A. U. Neumann,
A. S. Perelson,
W. Chen,
J. M. Leonard, and M. Markowitz.
1995.
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.
Nature
373:123-126[CrossRef][Medline].
|
| 7.
|
Holland, J. J.,
J. C. De la Torre,
D. K. Clarke, and E. Duarte.
1991.
Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses.
J. Virol.
65:2960-2967[Abstract/Free Full Text].
|
| 8.
|
Little, S. J.,
A. R. McLean,
C. A. Spina,
D. D. Richman, and D. V. Havlir.
1999.
Viral dynamics of acute HIV-1 infection.
J. Exp. Med.
190:841-850[Abstract/Free Full Text].
|
| 9.
|
Maeda, Y.,
D. J. Venzon, and H. Mitsuya.
1998.
Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance.
J. Infect. Dis.
177:1207-1213[Medline].
|
| 10.
|
Miralles, R.,
A. Moya, and S. F. Elena.
1999.
Effect of population patchiness and migration rates on the adaptation and divergence of vesicular stomatitis virus quasispecies populations.
J. Gen. Virol.
80:2051-2059[Abstract/Free Full Text].
|
| 11.
|
Nagylaki, T.
1992.
Introduction to theoretical population genetics.
Springer-Verlag, Berlin, Germany.
|
| 12.
|
Neumann, A. U.,
N. P. Lam,
H. Dahari,
D. R. Gretch,
T. E. Wiley,
T. J. Layden, and A. S. Perelson.
1998.
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.
Science
282:103-107[Abstract/Free Full Text].
|
| 13.
|
Neumann, A. U.,
R. Tubiana,
V. Calvez,
C. Robert,
T. S. Li,
H. Agut,
B. Autran, and C. Katlama.
1999.
HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment.
AIDS
13:677-683[CrossRef][Medline].
|
| 14.
|
Novella, I. S.,
S. F. Elena,
A. Moya,
E. Domingo, and J. J. Holland.
1995.
Size of genetic bottlenecks leading to virus fitness loss is determined by mean initial population fitness.
J. Virol.
69:2869-2872[Abstract].
|
| 15.
|
Nowak, M. A., and C. R. Bangham.
1996.
Population dynamics of immune responses to persistent viruses.
Science
272:74-79[Abstract].
|
| 16.
|
Perelson, A. S.,
A. U. Neumann,
M. Markowitz,
J. M. Leonard, and D. D. Ho.
1996.
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.
Science
271:1582-1586[Abstract].
|
| 17.
|
Phillips, A. N.,
A. R. McLean,
C. Loveday,
M. Tyrer,
M. Bofill,
H. Devereux,
S. Madge,
A. Dykoff,
A. Drinkwater,
A. Burke,
L. Huckett,
G. Janossy, and M. A. Johnson.
1999.
In vivo HIV-1 replicative capacity in early and advanced infection.
AIDS
13:67-73[CrossRef][Medline].
|
| 18.
|
Sevilla, N.,
C. M. Ruiz-Jarabo,
G. Gomez-Mariano,
E. Baranowski, and E. Domingo.
1998.
An RNA virus can adapt to the multiplicity of infection.
J. Gen. Virol.
79:2971-2980[Abstract].
|
| 19.
|
Wei, X.,
S. K. Ghosh,
M. E. Taylor,
V. A. Johnson,
E. A. Emini,
P. Deutsch,
J. D. Lifson,
S. Bonhoeffer,
M. A. Nowak,
B. H. Hahn, et al.
1995.
Viral dynamics in human immunodeficiency virus type 1 infection.
Nature
373:117-122[CrossRef][Medline].
|
| 20.
|
Zhang, Y. Y., and J. Summers.
2000.
Low dynamic state of viral competition in a chronic avian hepadnavirus infection.
J. Virol.
74:5257-5265[Abstract/Free Full Text].
|
Journal of Virology, December 2000, p. 11067-11072, Vol. 74, No. 23
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Armstrong, K. L., Lee, T.-H., Essex, M.
(2009). Replicative Capacity Differences of Thymidine Analog Resistance Mutations in Subtype B and C Human Immunodeficiency Virus Type 1. J. Virol.
83: 4051-4059
[Abstract]
[Full Text]
-
Paredes, R., Sagar, M., Marconi, V. C., Hoh, R., Martin, J. N., Parkin, N. T., Petropoulos, C. J., Deeks, S. G., Kuritzkes, D. R.
(2009). In Vivo Fitness Cost of the M184V Mutation in Multidrug-Resistant Human Immunodeficiency Virus Type 1 in the Absence of Lamivudine. J. Virol.
83: 2038-2043
[Abstract]
[Full Text]
-
Little, S. J., Frost, S. D. W., Wong, J. K., Smith, D. M., Pond, S. L. K., Ignacio, C. C., Parkin, N. T., Petropoulos, C. J., Richman, D. D.
(2008). Persistence of Transmitted Drug Resistance among Subjects with Primary Human Immunodeficiency Virus Infection. J. Virol.
82: 5510-5518
[Abstract]
[Full Text]
-
Petravic, J., Loh, L., Kent, S. J., Davenport, M. P.
(2008). CD4+ Target Cell Availability Determines the Dynamics of Immune Escape and Reversion In Vivo. J. Virol.
82: 4091-4101
[Abstract]
[Full Text]
-
He, Y., King, M. S., Kempf, D. J., Lu, L., Lim, H. B., Krishnan, P., Kati, W., Middleton, T., Molla, A.
(2008). Relative Replication Capacity and Selective Advantage Profiles of Protease Inhibitor-Resistant Hepatitis C Virus (HCV) NS3 Protease Mutants in the HCV Genotype 1b Replicon System. Antimicrob. Agents Chemother.
52: 1101-1110
[Abstract]
[Full Text]
-
Dykes, C., Demeter, L. M.
(2007). Clinical Significance of Human Immunodeficiency Virus Type 1 Replication Fitness. Clin. Microbiol. Rev.
20: 550-578
[Abstract]
[Full Text]
-
van Opijnen, T., Boerlijst, M. C., Berkhout, B.
(2006). Effects of random mutations in the human immunodeficiency virus type 1 transcriptional promoter on viral fitness in different host cell environments.. J. Virol.
80: 6678-6685
[Abstract]
[Full Text]
-
Dykes, C., Wang, J., Jin, X., Planelles, V., An, D. S., Tallo, A., Huang, Y., Wu, H., Demeter, L. M.
(2006). Evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture.. J. Clin. Microbiol.
44: 1930-1943
[Abstract]
[Full Text]
-
Wu, H., Huang, Y., Dykes, C., Liu, D., Ma, J., Perelson, A. S., Demeter, L. M.
(2006). Modeling and Estimation of Replication Fitness of Human Immunodeficiency Virus Type 1 In Vitro Experiments by Using a Growth Competition Assay. J. Virol.
80: 2380-2389
[Abstract]
[Full Text]
-
Voronin, Y., Overbaugh, J., Emerman, M.
(2005). Simian Immunodeficiency Virus Variants That Differ in Pathogenicity Differ in Fitness under Rapid Cell Turnover Conditions. J. Virol.
79: 15091-15098
[Abstract]
[Full Text]
-
van Opijnen, T., Jeeninga, R. E., Boerlijst, M. C., Pollakis, G. P., Zetterberg, V., Salminen, M., Berkhout, B.
(2004). Human Immunodeficiency Virus Type 1 Subtypes Have a Distinct Long Terminal Repeat That Determines the Replication Rate in a Host-Cell-Specific Manner. J. Virol.
78: 3675-3683
[Abstract]
[Full Text]
-
Goodenow, M. M., Rose, S. L., Tuttle, D. L., Sleasman, J. W.
(2003). HIV-1 fitness and macrophages. J. Leukoc. Biol.
74: 657-666
[Abstract]
[Full Text]
-
Huang, W., Gamarnik, A., Limoli, K., Petropoulos, C. J., Whitcomb, J. M.
(2002). Amino Acid Substitutions at Position 190 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Increase Susceptibility to Delavirdine and Impair Virus Replication. J. Virol.
77: 1512-1523
[Abstract]
[Full Text]
-
Resch, W., Ziermann, R., Parkin, N., Gamarnik, A., Swanstrom, R.
(2002). Nelfinavir-Resistant, Amprenavir-Hypersusceptible Strains of Human Immunodeficiency Virus Type 1 Carrying an N88S Mutation in Protease Have Reduced Infectivity, Reduced Replication Capacity, and Reduced Fitness and Process the Gag Polyprotein Precursor Aberrantly. J. Virol.
76: 8659-8666
[Abstract]
[Full Text]
-
Brenner, B. G., Routy, J.-P., Petrella, M., Moisi, D., Oliveira, M., Detorio, M., Spira, B., Essabag, V., Conway, B., Lalonde, R., Sekaly, R.-P., Wainberg, M. A.
(2002). Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary Infection. J. Virol.
76: 1753-1761
[Abstract]
[Full Text]
-
de Ronde, A., van Dooren, M., van der Hoek, L., Bouwhuis, D., de Rooij, E., van Gemen, B., de Boer, R., Goudsmit, J.
(2001). Establishment of New Transmissible and Drug-Sensitive Human Immunodeficiency Virus Type 1 Wild Types due to Transmission of Nucleoside Analogue-Resistant Virus. J. Virol.
75: 595-602
[Abstract]
[Full Text]